DOCSLIB.ORG

Io Brochurev4

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Io Brochurev4 ® IMMUNOTHERAPY UPDATES 2020 17TH JULY 2020 / WEBINAR ORGANIZED BY SUPPORTED BY CME Accredited CLICK HERE TO REGISTER E-Brochure Speaker Bio Shaheenah Dawood UAE Shaheenah Dawood is a Consultant medical oncologist and associate professor in clinical oncology in the United Arab Emirates. She currently leads the oncology clinical trials program at Mediclinic City Hospital Dubai. ® Axel Grothey USA Axel Grothey, MD, is a medical oncologist and Director of Gastrointestinal Cancer Research at West Cancer Center and Research Institute, in Germantown, Tennessee.Dr Grothey received his medical degree at Ruhr-Universität Bochum, Germany, and completed residencies at West German Tumor Center and the Institute of Pathology at the University of Essen and a residency and fellowship at the University of Bochum. Deborah Mukherji Lebanon Dr Deborah Mukherji is an Associate Professor of Clinical Medicine (Oncology) who joined the faculty of the AUBMC in June 2012. Dr Mukherji completed her advanced specialty training in Medical Oncology at Guys and St Thomas’s NHS Foundation Trust, London UK and was awarded a Post-Graduate Diploma in Oncology from the Institute of Cancer Research, University of London in 2011. Faraz Khan UAE Dr. Faraz Khan is a Consultant Hematologist and Medical Oncologist with over 15 years experience in treating cancer and various blood diseases. He completed his Internal Medicine, Hematology and Medical oncology training from the University of Connecticut, CT, USA and is triple board certified in Internal medicine, Hematology and Medical Oncology. 2 Speaker Bio Fathi Azribi UAE Dr Fathi Al Azribi is Consultant Medical Oncologist & Division Chief at Tawam Hospital Medical Oncology Fellowship Program Director Hamdy Abdul Azim Egypt Dr Azim is a Professor of Clinical Oncology and immediate past chairman of the Department of Clinical Oncology, Faculty of Medicine, Cairo University. He is the president of the Cairo Oncology Center, one of the largest private Cancer centers in the Middle East region. ® Ikram Burney Oman Dr Ikram Burney in consultant in Medical Oncology at SQUH. He graduated from Pakistan and received his training in Medical oncology at the Aga Khan University, Karachi, Hammersmith Hospital London, and Southampton University Hospitals in the UK. He worked as a consultant Oncologist at the Aga Khan University Hospital in Karachi, Pakistan. He has been working at SQUH, Oman since 2003 as a Senior consultant in Medical Oncology. Muath Nassar Kuwait Dr. Muath Nassar is Consultant medical oncologist, head of thoracic and sarcoma unit at Kuwait Cancer Control Center, Fellowship from Western University London Ontario, Canada . 3 Speaker Bio Mohsen Mokhtar Egypt Chief Medical Director Dr. Mohsen Mokhtar is a professor of clinical oncology in Al-Kasr Al-Aini Medical School. Dr. Mohsen assisted in developing the syllabus and course structure at Al-Kasr Al-Aini, as well as, supervised several research programs and theses. Nouri Benini UAE ® Nouri Bennini has served as Consultant Oncologist at the Tawam Hospital in Al Ain, United Arab Emirates, since 1999. He received his general medicine diploma in 1988 from the University of Constantine in Algeria and undertook residency in medical oncology at the University of Bordeaux, France. At the University of Montpellier, France, Dr Bennini specialised in breast diseases. He has published several scientific papers and contributed to a number of oncology conferences. Sanjay Popat UK Professor Popat has both a private and an NHS practice at The Royal Marsden. Professor Sanjay Popat is a Consultant Thoracic Medical Oncologist at The Royal Marsden and Honorary Clinical Senior Lecturer in the Molecular Genetics and Genomics Group at the National Heart and Lung Institute, Imperial College London. Tobias Arkenau UK Dr Hendrik-Tobias Arkenau is the founding Medical Director of Sarah Cannon Research Institute UK, and is currently serving as the Executive Medical Director for SCRI UK and Clinical Lead for the Hospital Corporation of America International Cancer Service Line.Dr Arkenau has vast experience in Early Oncology Clinical Drug Development with a special interest in gastrointestinal cancer and melanoma. 4 Speaker Bio Abdulrahman Zar Qatar Dr. Abdul Rahman Zar is currently a Consultant Medical Oncologist and Assistant Fellowship Director at the National Cancer Care Center and Research (NCCCR) of Hamad Medical Corporation. He is the Lead of Head and Neck MDT and CORE member of GI MDT. Dr Abdul Rahman Zar has received his medical degree from the Khyber Medical University, Peshawar, Pakistan. Christian Rolfo USA Christian Rolfo, MD, PhD, MBA is the director of the Thoracic Medical Oncology and the Early Clinical Trials at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC). He specializes in thoracic oncology, drug development and translational oncology. Peter Schmid UK Peter Schmid is Professor of Cancer Medicine and Lead of the Centre of Experimental Cancer Medicine at Barts Cancer Institute. He is the Clinical Director of the St. Bartholomew Breast Cancer Centre and Honorary Consultant Medical Oncologist at Barts Hospital. He also leads the Cancer Immune Therapy group at Barts Hospital. Pier Luigi Zinzani Italy Pier Luigi Zinzani is Professor in Department of Experimental, Diagnostic and Specialty Medicine – DIMES at University of Bologna. He has been Awarded a “Post-Doctoral Fellowship in Medical Physics” released by the “Roger Williams Cancer Ospitale” of Providence (USA) in 1989 5 Program 17:00 - 17:10 Welcome Key Note Shaheenah Dawood, UAE 17:12 – 19:25 Session 1 Chair: Faraz Khan, UAE 17:12 – 17:32 In the era of IO dual immunotherapy in the management of front line NSCLC Supported by BMS Fathi Al Azribi, UAE 17:35 – 17:55 Immunotherapy updates in breast cancer Supported by Roche Peter Schmid, UK 17:57 – 18:12 Immunotherapy cases in breast cancer Hamdy A. Azim, Egypt 18:14 – 18:29 Immunotherapy updates in GI malignancies Axel Grothey, USA 18:31 – 18:46 Immunotherapy updates in GU malignancies Deborah Mukherji, Lebanon ® 18:48 – 19:03 Immunotherapy updates in lung cancer Sanjay Popat, UK 19:05 – 19:25 Case Studies in first line management of NSCLC Christan Rolfo, USA 19:25 – 19:40 Break 6 Program 19:40 – 20:34 Session 2 Chair: Nouri Bennini, UAE 19:40 – 20:00 Updates on role of checkpoint inhibitors in classical Hodgkin Lymphoma Pier Luigi Zinzani, Italy 20:02 – 20:17 Defining the role of Dual immunotherapy approaches in solid malignancies Tobias Arkenau, UK 20:19 – 20:34 Challenging case discussion sessions highlighting management of toxicity related to immunotherapy Mohsen Mokhtar, Egypt 20:36 – 21:06 Panel discussion Moderator: Shaheenah Dawood, UAE Panellist: Hamdy A. Azim, Egypt | Tobias Arkenau, UK | Mohsen Mokhtar, Egypt | Sanjay Popat, UK Deborah Mukherji, Lebanon | Axel Grothey, USA | Fathi Al Azribi, UAE Abdulrahman Zar, Qatar | Ikram Burney, Oman | Muath Nassar, Kuwait | Peter Schmid, UK 21:08 – 21:15 Closing Remark Shaheenah Dawood 7 Next Virtual Events ® VISIT OUR WEBSITE FOR REGISTRATION 24 JULY 2020 & MORE DETAILS: CANCERCONGRESS.AE Timing: 17:00 - 21: 30 Hrs BREAST CANCER UPDATES 2020 VISIT OUR WEBSITE FOR REGISTRATION 21 AUGUST 2020 & MORE DETAILS: IBRCAF.COM VISIT OUR WEBSITE FOR REGISTRATION 22 - 23 AUGUST 2020 & MORE DETAILS: APGCS.COM ORGANIZED BY INDEX Holding Headquarters, Road # D-62, Opposite Nad Al Hamar P.O. Box: 13636, Dubai, UAE | Tel: +971 4 520 8888, Fax: +971 4 338 4193 Email: [email protected], Website: cancercongress.ae.
Load more

Recommended publications
  • The COVID-19 Response in the United Arab Emirates
    WORLD VIEW | SERIES world view | SERIES The COVID-19 response in the Credit: United Arab United Arab Emirates: challenges and Emirates University, UAE opportunities Like other countries in the region, the United Arab Emirates (UAE) was deeply afected by the pandemic. However, its foresight and proactive policies helped to create opportunities out of the challenges and spurred the development of trilateral collaborations involving government, academia and industry. he UAE is a young country located 4 Humanity phase 3 trial with the The investment in national COVID- in the Arabian Peninsula and was inactivated SARS-CoV-2 vaccine in July 19 research collaborations has resulted in Tthe first in the region to report 2020 and the Sputnik V-UAE phase 3 trial several important studies. To highlight a SARS-CoV-2 cases. The UAE government’s in January 2021. This challenge provided a few, the first and largest population-based response to the pandemic was swift golden opportunity for scientists to conduct cross-sectional seroprevalence study in the and decisive. Effective public health high-quality research that spanned many UAE was conducted in July 2020 with more measures were immediately implemented, fields, including epidemiology, diagnostics than 13,000 participants. The study revealed beginning with activating an emergency and therapeutics. a low seroprevalence among residents of response system, issuing guidance for In March 2020, the three main health households in the Emirate of Abu Dhabi and risk communication with the public, authorities in the UAE (the federal Ministry substantially higher seroprevalence in labor building field hospitals and providing rapid of Health and Prevention; the Department camps, reflecting the high efficiency with drive-through PCR testing.
    [Show full text]
  • Saudi Arabia
    Durham E-Theses The role of the gulf cooperation council in the economic development of the Gulf States Al-Sani, Rashed Mezed Ali How to cite: Al-Sani, Rashed Mezed Ali (1992) The role of the gulf cooperation council in the economic development of the Gulf States, Durham theses, Durham University. Available at Durham E-Theses Online: http://etheses.dur.ac.uk/6119/ Use policy The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-prot purposes provided that: • a full bibliographic reference is made to the original source • a link is made to the metadata record in Durham E-Theses • the full-text is not changed in any way The full-text must not be sold in any format or medium without the formal permission of the copyright holders. Please consult the full Durham E-Theses policy for further details. Academic Support Oce, Durham University, University Oce, Old Elvet, Durham DH1 3HP e-mail: [email protected] Tel: +44 0191 334 6107 http://etheses.dur.ac.uk 2 THE ROLE OF THE GULF COOPERATION COUNCIL IN THE ECONOMIC DEVELOPMENT OF THE GULF STATES by RASHED MEZED ALI AL-SANI A thesis submitted for the degree of Doctor of Philosophy University of Durham Faculty of Social Sciences September 1992 The copyright of this thesis rests with the author. No quotation from it should be published without his prior written consent and information derived from it should be acknowledged.
    [Show full text]
  • List of Hospital Providers Within UAE for Daman's Health Insurance Plans
    List of Hospital Providers within UAE for Daman ’s Health Insurance Plans (InsertDaman TitleProvider Here) Network - List of Hospitals within UAE for Daman’s Health Insurance Plans This document lists out the Hospitals available in the Network for Daman’s Health Insurance Plan (including Essential Benefits Plan, Classic, Care, Secure, Core, Select, Enhanced, Premier and CoGenio Plan) members. Daman also covers its members for other inpatient and outpatient services in its network of Health Service Providers (including pharmacies, polyclinics, diagnostic centers, etc.) For more details on the other health service providers, please refer to the Provider Network Directory of your plan on our website www.damanhealth.ae or call us on the toll free number mentioned on your Daman Card. Edition: October 01, 2015 Exclusive 1 covers CoGenio, Premier, Premier DNE, Enhanced Platinum Plus, Enhanced Platinum, Select Platinum Plus, Select Platinum, Care Platinum DNE, Enhanced Gold Plus, Enhanced Gold, Select Gold Plus, Select Gold, Care Gold DNE Plans Comprehensive 2 covers Enhanced Silver Plus, Select Silver Plus, Enhanced Silver, Select Silver Plans Comprehensive 3 covers Enhanced Bronze, Select Bronze Plans Standard 2 covers Care Silver DNE Plan Standard 3 covers Care Bronze DNE Plan Essential 5 covers Core Silver, Secure Silver, Core Silver R, Secure Silver R, Core Bronze, Secure Bronze, Care Chrome DNE, Classic Chrome, Classic Bronze Plans 06 covers Classic Bronze and Classic Chrome Plans, within Emirate of Dubai and Northern Emirates 08
    [Show full text]
  • Physician User Satisfaction with an Electronic Medical Records System in Primary Healthcare Centres in Al Ain: a Qualitative Study
    Downloaded from http://bmjopen.bmj.com/ on November 14, 2015 - Published by group.bmj.com Open Access Research Physician user satisfaction with an electronic medical records system in primary healthcare centres in Al Ain: a qualitative study Shamma Al Alawi,1 Aysha Al Dhaheri,1 Durra Al Baloushi,1 Mouza Al Dhaheri,2 Engela A M Prinsloo3 To cite: Al Alawi S, Al ABSTRACT Strengths and limitations of this study Dhaheri A, Al Baloushi D, Objectives: To explore physician satisfaction with an et al. Physician user electronic medical records (EMR) system, to identify ▪ satisfaction with an electronic The electronic medical records (EMR) system and explore the main limitations of the system and medical records system in (Cerner) was introduced in the Emirate of Abu primary healthcare centres in finally to submit recommendations to address these Dhabi, but only Al Ain clinics were selected for Al Ain: a qualitative study. limitations. the study and, owing to the study design, the BMJ Open 2014;4:e005569. Design: A descriptive qualitative study that entailed findings cannot be generalised. doi:10.1136/bmjopen-2014- three focus group interviews was performed among ▪ This is the first local study to address EMR user 005569 physicians using open-ended questions. The interviews satisfaction adds a new user perspective. were audiotaped, documented and transcribed ▪ This study focused on the primary healthcare ▸ Prepublication history and verbatim. The themes were explored and analysed in physician EMR users excluding hospital users additional material is different categories. and related healthcare professionals. available. To view please visit Setting: The study was conducted in primary ▪ Method of focus-group recruitment contributed the journal (http://dx.doi.org/ healthcare centres (PHC) in Al Ain, United Arab to selection bias.
    [Show full text]
  • List of Pharmaceutical Providers Within UAE for Daman's Health Insurance Plans
    List of Pharmaceutical Providers within UAE for Daman ’s Health Insurance Plans (InsertDaman TitleProvider Here) Network - List of Pharmaceutical Providers within UAE for Daman’s Health Insurance Plans This document lists out the Pharmacies and Hospitals available in Daman’s Network, dispensing prescribed medicines, for Daman’s Health Insurance Plan (including Essential Benefits Plan, Classic, Care, Secure, Core, Select, Enhanced, Premier and CoGenio Plan) members. Daman also covers its members for other inpatient and outpatient services in its network of Health Service Providers (including hospitals, polyclinics, diagnostic centers, etc.). For more details on the other health service providers, please refer to the Provider Network Directory of your plan on our website www.damanhealth.ae or call us on the toll free number mentioned on your Daman Card. Edition: October 01, 2015 Exclusive 1 covers CoGenio, Premier, Premier DNE, Enhanced Platinum Plus, Select Platinum Plus, Enhanced Platinum, Select Platinum, Care Platinum DNE, Enhanced Gold Plus, Select Gold Plus, Enhanced Gold, Select Gold, Care Gold DNE Plans Comprehensive 2 covers Enhanced Silver Plus, Select Silver Plus, Enhanced Silver, Select Silver Plans Comprehensive 3 covers Enhanced Bronze, Select Bronze Plans Standard 2 covers Care Silver DNE Plan Standard 3 covers Care Bronze DNE Plan Essential 5 covers Core Silver, Secure Silver, Core Silver R, Secure Silver R, Core Bronze, Secure Bronze, Care Chrome DNE, Classic Chrome, Classic Bronze Plans 06 covers Classic Bronze
    [Show full text]
  • Proceedings of 2Nd International Radiation Oncology Conference Muscat, Sultanate of Oman
    Abstract Proceedings of 2nd International Radiation Oncology Conference Muscat, Sultanate of Oman. 25-27 February 2009 Image-Guided Adaptive Radiation Therapy: The mammographical dense breast tissue (ACR grade 3 and 4) reduces Wave of the Future the sensitivity of mammography to 50-60% and is the reason for additional ultrasound in breast cancer screening and diagnostic Prof. Jacob (Jake) Van Dyk, London Regional Cancer Program/ work up. Three-dimensional (3D) and four-dimensional (4D) London Health Sciences Centre and the University of Western Ontario, mammasonography is the most recent development in breast 790 Commissioners Rd E, London, Ontario, CANADA N6A 4L6. ultrasound technology providing additional aspects to conventional The Main Objectives are 1) To define and describe image-guided 2D sonography. 4D ultrasound offers almost real time 3D rendered radiation therapy (IGRT) and adaptive radiation therapy (ART), image information and is taken as a basis of multidimensional 2) To demonstrate the benefits and need for IGART, 3) To show imaging of the breast. In the following section volume contrast the trends and future directions of IGART. imaging (VCI), inversion mode rendering, virtual computer- Recent technological advances in radiation treatment have been aided lesion analysis (VoCal), tomographic ultrasound imaging achieved through the evolution of computer technology. Intensity (TUI), extended view (XTD View) documentation and real-4D modulated radiation treatment uses sophisticated automated breast biopsy in combination with 3D-targeting technique will be inverse optimization software in treatment planning computers discussed. Static volume contrast imaging (VCI) offers to study combined with computer-controlled multileaf collimator delivery a static three-dimensional dataset with preselected slice thickness systems.
    [Show full text]
  • The Yield of Blood Cultures Performed at Tawam Hospital for All Children
    Abstracts / Journal of Infection and Public Health 12 (2019) 109–151 137 reported in Riyadh region (50.36%), and minority was in Jazan The yield of blood cultures performed at Tawam region (0.12%). The generation of infection was determined from Hospital for all children from all department three main sources; Primary infection was 24.16% (camel contact H. Gindeel and/or consumption of their raw milk), Secondary infection was 38.34% (hospital acquired 92.16% and community acquired 13.48%) Tawam Hospital and un-identified source 37.5% of all cases. MERS infection caused 368 death among 829 cases (case fatality All blood cultures (BCs) were taken from January 2013 up rate CFR = 44.4%) for all the period. The mortality rate according to to June 2013 for children from birth up to 15 years old at the source of infection was; un-identified source (44%), secondary Tawam hospital. A retrospective cross-sectional descriptive ana- infection (32.6%, including 97.5% hospital acquired), and primary lytic study was performed to them. One hundred seventy one infection (23.4%). (6%) were yielded from 3015 BCs. These organisms were classi- Conclusion: Incident and mortality rates were found signif- fied into true bacteremia (62%) and false positive cultures (38%). icantly decreased from 2015 to 2017. Age group and source of The true bacteremia was compared with negative cultures by gen- infection demonstrated high risk population. Identification of MERS der, age groups, fever, and the presenting condition of the child, epidemiological characteristics support the control plan and pre- oncology patient, immunodeficiency patient, and any child hav- ventive measures for improving public health impact in Saudi ing indwelling catheter or other devises and any cardiovascular Arabia.
    [Show full text]
  • (United Arab Emirates) Just a Quic
    Applied Geography 95 (2018) 88–100 Contents lists available at ScienceDirect Applied Geography journal homepage: www.elsevier.com/locate/apgeog A district and sector land-use and landscape analysis of urban sprawl in Al T Ain municipality (United Arab Emirates): Just a quick conversion from sand to a built-up environment? ∗ Sayed Adnan Sharafa, Pere Serrab, , David Sauríb a Department of Municipal Affairs, Al Ain City Municipality, United Arab Emirates b Department of Geography, Universitat Autònoma de Barcelona, Spain ABSTRACT Al Ain, located in the United Arab Emirates, is an example of medium-sized desert city with rapid urban growth guided by two master plans from the 1980s. The present study is an empirical contribution to analyse the spatial- temporal land-use and land-cover (LULC) dynamics from 1984 to 2014 applying three different tools: i) a Base Map of Al Ain Town Planning from 2014 combined with four Landsat images to extract the main LULC changes; ii) a landscape analysis using spatial metrics to determine processes of sprawl; iii) statistical analysis of census data at district scale to obtain a better understanding of changes. Results show an intensive urban sprawl mainly, between 1984 and 1990, with an increase in residential land and in services, very clear in the Western sector as proposed by the 1980s Master Plan. Urban compaction was observed in the Centre and Downtown sectors whereas in the Northern and Southern sectors the urban pattern was leapfrogging and associated to the main roads. Simultaneously, and as a particularity of Al Ain, an intensive process of agricultural sprawl occurred, mainly from 1990 to 2000.
    [Show full text]
  • Mental Health in the Eastern Mediterranean Region Reaching the Unreached
    WHO Regional Publications, Eastern Mediterranean Series 29 Mental health in the Eastern Mediterranean Region: reaching theunreached reaching Mediterranean Region: Mental health intheEastern Mental health in the Eastern Mediterranean Region: reaching the unreached Mental health in the In 2001 mental health was brought to the focus of international attention when the World Health Organization devoted its World Health Day campaign and The world health report to the subject. In many countries around the world, and particularly in Eastern Mediterranean Region developing countries, mental health has long been a neglected area of health care, more often than not considered in terms of institutions and exclusion, rather than the care and needs of the human being. Current knowledge emphasizes early identification Reaching the unreached and intervention, care in the community and the rights of mentally ill individuals. The countries of the Eastern Mediterranean Region represent many challenges for the organization of mental health care. Many countries are in a state of rapid social change, some are in conflict or suffering the aftermath of conflict, while others are witnessing the growing problem of substance abuse, with associated HIV/AIDS rapidly becoming a public health priority. This publication addresses three aspects: the planning of mental health services; the current mental health situation in each of the countries of the Region, along with the innovative approaches developed during the past two decades, and the challenges and opportunities for addressing the mental health needs of the diverse populations. Bringing together the experiences of the Region provides an opportunity to learn from the past as well as for greater collaboration and cooperation in the future between countries facing similar problems.
    [Show full text]
  • UNITED ARAB EMIRATES Country Information Sheet
    UNITED ARAB EMIRATES Country Information Sheet © International Affiliate of the Academy of Nutrition and Dietetics 2019 Credentialing Verification Authorities: Department of Health (DOH), Dubai Health Authority (DHA), Ministry of Health (Ajman, Sharjah and the rest of North Emirates) Communications: Arabic and English Ongoing Nutrition Activities in UAE 1. National Dietetic Association The Emirates Clinical Nutrition Society is a non-profit medical society formed in 2016 by a group of clinical nutritionists. Its aim is to provide all members with a common platform for network where they can all improve their scientific knowledge, raise their level of performance and increase health public awareness. This society also aims to change the lifestyle and eating habits of communities here in UAE. Board directors are: Mrs. Afra Bin Katta – President Ms. Masooma Al Jasmi – Vice President Ms. Resia Al Ketbi – General Secretary Mrs. Alia Al Showab – Committee Chairperson Related organizations Emirates Clinical Nutrition Society UAE Nutrition Group Address: Dubai, Mamzar Area, Al Address: Tawam Hospital Al-Ain, UAE Wahaida Road Facebook: UAE Nutrition Community Tel: +971-4-255-6655 Email: [email protected] Fax: +971-4-255-6363 Fax: +9713-7072844 Web: www.ema.ae 2. National Nutrition Programmes/Projects Emirates Institute for Health and Safety Abu-Dhabi Food control Address: Khalifa Bin Zayed Street Authority (ADFCA) Abu-Dhabi, UAE Address: Mohamed Bin Zayed Tel: +9712-627-7767 City opposite Mezyed Mall Email: [email protected] Abu-Dhabi, UAE Website: www.eihs.ae Website: www.adfca.ae Email: [email protected] Dubai International food Safety Conference (DIFSC) Dubai, UAE Website: www.foodsafetydubai.com 3.
    [Show full text]
  • Company Profile Page I/10
    Al Masfoufa Engineering Laboratory your partner in quality services ﻣﺨﺘﺒﺮاﻟﻤﺼﻔﻮﻓﺔ اﻟﻬﻨﺪﺳﻲ ﺷﺮﻳﻜﻜﻢ ﻓﻲ ﺟﻮدة اﻟﺨﺪﻣﺎت Partner for Quality Services Al Masfoufa Engineering Laboratory Office P.O. Box 84618 Tel.: 03-722 3265 Fax: 03-722 3264 Behind Lulu Hypermarket Sanaiya, Al Ain, U.A.E. Email: [email protected] / [email protected] Website: www.almasfoufaengineering.ae Contact Persons: Eng. Abdul Qader H. Abrash Managing Director Mobile: 050 - 643 1575 Ala'a Edin H. Brash Operation Manager Mobile: 050- 6525 963 Company Profile Page i/10 Al Masfoufa Engineering Laboratory your partner in quality services ﻣﺨﺘﺒﺮ اﻟﻤﺼﻔﻮﻓﺔ اﻟﻬﻨﺪﺳﻲ ﺷﺮﻳﻜﻜﻢ ﻓﻲ ﺟﻮدة Partner for Quality Services TABLE OF CONTENTS Page No. 1. Introduction ............................................................................................... 1 2. Services ♦ Geotechnical Investigation …………………………………………………… 2 ♦ Topographical Survey ………………………………………………………… 3 ♦ Geophysical Survey ………………………………………………………….. 4 ♦ Material Testing ………………………………………………………………. 6 3. Personnel ♦ Technical Staff ……………………………………………………………….. 7 ♦ Laboratory ……………………………………………………………………. 8 ♦ Drillers ………………………………………………………………………… 9 ♦ Administration ……………………………………………………………….. 10 Appendix ♦ Organizational Chart ♦ Licenses & Certificate ♦ Major Site Investigation Projects ♦ Directorate of Military Works Site Investigation Projects ♦ Geophysical Survey Projects ♦ Major Material Testing Projects ♦ Client Approval/Registration Company Profile Page ii/10 Al Masfoufa Engineering Laboratory your partner in quality services
    [Show full text]
  • Musculoskeletal Brucellosis in Adults in the United Arab Emirates: a Retrospective Study
    Musculoskeletal Brucellosis in Adults in the United Arab Emirates: A Retrospective Study Authors: *Shamma Al Nokhatha,1 Fatima AlKindi,2 Shaima Al Yassi,2 Rayhan Hashmey3 1. Division of Rheumatology, Tawam Hospital, Al Ain, United Arab Emirates 2. Division of General Internal Medicine, Tawam Hospital, Al Ain, United Arab Emirates 3. Division of Infectious Diseases, Tawam Hospital, Al Ain, United Arab Emirates *Correspondence to [email protected] Disclosure: The authors have declared no conflicts of interest. Received: 22.11.20 Accepted: 15.01.21 Keywords: Arthritis, brucellosis, musculoskeletal (MSK) involvement, sacroiliac joint (SIJ), United Arab Emirates (UAE). Citation: EMJ. 2021; DOI/10.33590/emj/20-00271 Abstract Introduction: Brucellosis is a zoonotic infection caused by the aerobic Gram-negative bacteria coccobacilli, and is considered a public health problem in the Mediterranean region and Arabian Peninsula. This paper studied the clinical characteristics of musculoskeletal brucellosis and the outcomes of treatment in Al Ain City, United Arab Emirates. Method: A retrospective chart review study was conducted at Tawam Hospital over seven years: January 2009–January 2016. Risk factors for brucellosis, musculoskeletal (MSK) manifestations, duration of Brucella infection (acute, subacute, chronic), and treatment were studied. Results: A total of 99 patients were diagnosed with brucellosis during the study period; the mean age was 44 years, the majority were males (71%), and the male to female ratio was 3:1. The most common risk factor for Brucella infection in the cohort was drinking raw milk (43.4%). Fever was the most common presenting symptoms (93%), followed by arthralgia, fatigue, and loss of appetite in 35, 21, and 14%, respectively.
    [Show full text]